ES2056983T3 - Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. - Google Patents

Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.

Info

Publication number
ES2056983T3
ES2056983T3 ES89104251T ES89104251T ES2056983T3 ES 2056983 T3 ES2056983 T3 ES 2056983T3 ES 89104251 T ES89104251 T ES 89104251T ES 89104251 T ES89104251 T ES 89104251T ES 2056983 T3 ES2056983 T3 ES 2056983T3
Authority
ES
Spain
Prior art keywords
inhibit
lipoxigenase
biosynthesis
metabolites
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104251T
Other languages
English (en)
Inventor
Edward S Lazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharmaceuticals Inc filed Critical BOEHRINGER INGELHEIM PHARMA
Application granted granted Critical
Publication of ES2056983T3 publication Critical patent/ES2056983T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA INHIBEN 5 - LIPOOXIGENADO Y SE USAN EN EL TRATAMIENTO DE LA INFLAMACION.
ES89104251T 1988-03-21 1989-03-10 Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. Expired - Lifetime ES2056983T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17051288A 1988-03-21 1988-03-21

Publications (1)

Publication Number Publication Date
ES2056983T3 true ES2056983T3 (es) 1994-10-16

Family

ID=22620151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89104251T Expired - Lifetime ES2056983T3 (es) 1988-03-21 1989-03-10 Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.

Country Status (16)

Country Link
EP (1) EP0334119B1 (es)
JP (1) JPH024729A (es)
KR (1) KR890014514A (es)
AU (1) AU628324B2 (es)
DD (1) DD283602A5 (es)
DE (1) DE68907095T2 (es)
DK (1) DK134489A (es)
ES (1) ES2056983T3 (es)
FI (1) FI891295A (es)
HU (2) HU9201174D0 (es)
IL (1) IL89666A0 (es)
NO (1) NO169648C (es)
NZ (1) NZ228410A (es)
PH (1) PH26928A (es)
PT (1) PT90066B (es)
ZA (1) ZA892086B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626955A1 (en) * 1992-02-11 1994-12-07 Allergan, Inc. Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
ES2089736T3 (es) * 1992-10-28 1996-10-01 Shionogi & Co Derivados de bencilideno.
ES2087019B1 (es) * 1994-02-08 1997-03-16 Bobel246 S L Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6376524B1 (en) * 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
ES2401077T3 (es) 2001-01-18 2013-04-16 Glaxo Group Limited Nuevos derivados 1,2-difenileteno para el tratamiento de enfermedades inmunológicas
MXPA04000695A (es) 2001-07-23 2005-08-26 Galileo Pharmaceuticals Inc Compuestos citoprotectores, formulaciones farmaceuticas y cosmeticas y metodos.
US20070185217A1 (en) 2003-12-23 2007-08-09 Abraxis Bioscience, Inc. Propofol analogs, process for their preparation, and methods of use
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
EP3706725A4 (en) 2017-11-10 2021-08-25 Dermavant Sciences GmbH PROCESS FOR THE PREPARATION OF TAPINAROF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3188315A (en) * 1960-05-18 1965-06-08 Schering Corp Novel compounds for lowering blood cholesterol levels
FR1390978A (fr) * 1963-11-20 1965-03-05 Ind Chimique Sa Procédé de préparation de l'alpha-(thiényl-2) 4-hydroxystilbène et de quelques dérivés et produits obtenus
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1338645C (en) * 1987-01-06 1996-10-15 George R. Pettit Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"

Also Published As

Publication number Publication date
PT90066B (pt) 1994-05-31
PT90066A (pt) 1989-11-10
KR890014514A (ko) 1989-10-24
HU9201174D0 (en) 1992-07-28
FI891295A0 (fi) 1989-03-20
DE68907095D1 (de) 1993-07-22
ZA892086B (en) 1990-11-28
IL89666A0 (en) 1989-09-28
FI891295A (fi) 1989-09-22
DK134489D0 (da) 1989-03-20
EP0334119A1 (en) 1989-09-27
AU3151489A (en) 1989-09-21
HUT50093A (en) 1989-12-28
EP0334119B1 (en) 1993-06-16
DK134489A (da) 1989-09-22
DE68907095T2 (de) 1994-01-05
PH26928A (en) 1992-12-03
JPH024729A (ja) 1990-01-09
AU628324B2 (en) 1992-09-17
DD283602A5 (de) 1990-10-17
NZ228410A (en) 1993-08-26
NO891114L (no) 1989-09-22
NO891114D0 (no) 1989-03-15
NO169648C (no) 1992-07-22
HU207858B (en) 1993-06-28
NO169648B (no) 1992-04-13

Similar Documents

Publication Publication Date Title
ES552627A0 (es) Procedimiento para la preparacion de carbamatos de fenilo
IT8821542A0 (it) Composti attivi come inibitori della biosintesi del colesterolo.
ES8708127A1 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
PT956282E (pt) Derivados de acido sulfinico e sua preparacao e utilizacao
SE8804036D0 (sv) New use of 11,28-dioxa-4-azatricyclo(22.3.1.0?724,9 )octacos-18-ene derivatives and pharmaceutical compositions containing them
IT8967853A0 (it) Apparecchiatura per il trattamento di cellule
NO942994D0 (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
DK324286A (da) 1-substituerede oxindol-3-carboxamider og deres anvendelse som antiinflammatoriske og analgetiske midler
MY109722A (en) Azaoxindole derivatives.
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
IT1156745B (it) Farmaci contenenti composti sterolici 15-ossigenati e procedimento per impedire la biosintesi di acido mevalonico
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
IT1074295B (it) Procedimento per la preparazione di derivati dell acido fusidico particolarmente utili come batteri cidi
FI950842A0 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
FR2395998A1 (fr) Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
IT8721697A0 (it) Derivati dell'acido 7-ossabiciclo (2.2.1.) eptan idrossammico utili come inibitori duplici
AU585279B2 (en) Pesticidal biphenylyloxy and biphenylylalkoxy aryl acyl urea compounds
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
ES2090806T3 (es) Acilsulfonamido- y sulfonamido-piridina-2-esteres de acidos carboxilicos, asi como sus piridina-n-oxidos, procedimientos para su preparacion y su utilizacion como medicamentos.
MX9203255A (es) Compuestos para inhibir la biosintesis de metabolitos derivados de la lipoxigenasa del acido araquidonico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334119

Country of ref document: ES